Medications
Ozempic, Wegovy, Mounjaro, Zepbound, Compounded Semaglutide, Compounded Tirzepatide
Monthly Cost
$129-$329/mo
Speed to Start
Fast
Est. 2020
About Eden
Eden positions itself as a straightforward, affordable GLP-1 telehealth platform with flat upfront pricing and no hidden fees. Founded in 2020, the platform offers one of the broadest medication menus available — both brand-name options (Ozempic, Wegovy, Mounjaro, Zepbound) and compounded alternatives (semaglutide, tirzepatide) — giving patients flexibility across price points.
Monthly pricing ranges from $129 to $329, which is mid-range for the market. Eden differentiates with microdose options — allowing patients to start at lower doses and titrate up gradually, which can reduce side effects and help patients who are hesitant about jumping straight to standard dosing.
With a 4.4 Trustpilot rating across 3,300+ reviews, Eden demonstrates strong patient satisfaction. The review volume and rating combination puts them in the upper tier for reputation, though the lack of a BBB listing means there’s one less external trust signal.
Clinically, Eden falls in the middle. Provider quality is rated medium, and the platform doesn’t include lab testing or dietitian access — both of which are increasingly standard among top-tier competitors. Ongoing support is moderate rather than high, meaning patients who need more hands-on guidance may find the experience lacking.
Trust and compliance transparency is also rated medium, and the CoA status for compounded medications is unknown. For a platform selling compounded GLP-1s, this is a gap worth noting. The fast onboarding and nationwide availability are clear positives, making Eden easy to start with even if the ongoing clinical depth doesn’t match the best in class.
Eden GLP-1 Medications
At a Glance
Medications Offered
Ozempic, Wegovy, Mounjaro, Zepbound, Compounded Semaglutide, Compounded Tirzepatide
Both
Cost & Insurance
- Monthly: $129-$329/mo
- 6-month estimate: $774-$1,974
- Insurance: No
- Self-pay: Yes
Clinical Features
- Lab testing: No
- Dietitian access: No
- Verified Pharmacy: Licensed U.S. 503A compounding pharmacies; VP of Pharmacy Operations on staff; extensive vetting process; partnerships in all 50 states
- BBB Rating: –
Delivery & Access
- Format: Both
- Nationwide telehealth: Yes
- Speed: Fast
- Spanish-speaking providers: Not available
Start your GLP-1 weight loss journey with Eden today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.
What the Eden Intake Looks Like
We walked through Eden’s full GLP-1 intake ourselves, from the opening weight-loss goal screen to the final 1-month supply checkout. Here’s what a prospective patient encounters before the clinician review begins.
/ 10
Solid. Two comorbidity multi-select screens cover FDA black-box family history, pancreatitis, gallbladder disease, gastroparesis, and T1D. An unusually specific drug-interaction list names common sulfonylureas, DPP-4 inhibitors, and insulin.
/ 10
Moderate. Phone and SMS consent collected mid-flow; full account creation with password happens after the clinical questions but before checkout. A 5-part legal consent bundle is required before treatment selection.
The 10 Stages
Clinical Safety Screens Performed
Eden’s current-medications screen is unusually specific. Rather than asking “are you on any medications?”, it explicitly names sulfonylureas (glimepiride / glipizide / glyburide), DPP-4 inhibitors (sitagliptin / saxagliptin / linagliptin / alogliptin), and insulin. These are the three medication classes that can cause dangerous hypoglycemia when combined with a GLP-1, so checking for them by name is a genuinely useful safety step — most intakes just ask a generic “other meds?” free-text field and rely on the clinician to catch the interaction later.
Near the end of the intake, Eden presents a choice between tirzepatide (described as “dual-action formula that targets two hunger receptors to significantly curb cravings and appetite”) and semaglutide (described as “single-action formula that mimics natural hormones to help you feel fuller for longer periods”). The patient’s selection is fed to the clinician as a preference, not a prescription. The final prescribed product is still determined by the provider’s review, but giving the patient a transparent look at the two active-ingredient options is relatively rare.
Eden’s intake does not include a validated PHQ-2 or PHQ-9 depression instrument, a suicide or self-harm question, a substance-use or alcohol screen, an actual blood-pressure reading, or an explicit pregnancy check. The eating-disorder check exists but is buried as one checkbox option in the second comorbidity multi-select rather than being a dedicated screen with its own safety language. Gender is captured as Male or Female only, with no non-binary or prefer-not-to-answer options.
At checkout, Eden’s 1-Month Supply of personalized compounded tirzepatide is billed at $329, with an $80 first-order promo applied automatically, bringing the due-today total to $249. The plan is FSA/HSA eligible and the flow notes the patient won’t be charged unless a provider determines the treatment is appropriate.
Source: GLP-1.Reviews editorial walkthrough on April 13, 2026. We completed every screen of Eden’s weight-loss intake using a representative GLP-1 candidate persona and stopped before submitting any payment information.
Opens tryeden.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.
